News for Red Violet, Inc. (RDVT)

Red Violet Inc (RDVT) is set to release its Q4 2024 earnings on Feb 27, 2025. The consensus estimate for Q4 2024 revenue is $18.08 million, and the earnings are

BOCA RATON, Fla., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Red Violet, Inc. ( RDVT), a leading analytics and information solutions provider, announced today that it

On December 31, 2024, ASHFORD CAPITAL MANAGEMENT INC (Trades, Portfolio) made a strategic decision to reduce its holdings in Red Violet Inc (RDVT) by 102,336 sh

**media[513603]**

Red Violet (RDVT) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

The 2nd largest local REALTOR® Association in the state of Kentucky contracts to make FOREWARN services available for its 4,000+ real estate professional memb

Shares of Red Violet Inc (RDVT) surged 3.90% in mid-day trading on Dec 6. The stock reached an intraday high of $38.75, before settling at $38.60, up from i

BOCA RATON, Fla., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Red Violet, Inc. ( RDVT), a leading analytics and information solutions provider, announced today that its

Red Violet (RDVT) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Red Violet director Peter Benz sells $935,429 in stock

Shares of Red Violet Inc (RDVT) fell 5.30% in mid-day trading on Nov 26. The stock reached an intraday low of $36.61, before recovering slightly to $36.73,

On November 25, 2024, Jeffrey Dell, Chief Information Officer at Red Violet Inc's subsidiary, executed a sale of 10,000 shares of Red Violet Inc (RDVT). Followi

The record drop in Globe Life Inc. this week extended a streak of wins for the short-selling group that released a report against the insurance company.

(Bloomberg) -- The record drop in Globe Life Inc. this week extended a streak of wins for the short-selling group that released a report against the insurance company. Most Read from BloombergIsrael Bracing for Unprecedented Direct Iran Attack in DaysApple Plans to Overhaul Entire Mac Line With AI-Focused M4 ChipsRussian Attacks on Ukraine Stoke Fears Army Near Breaking PointUS Sees Imminent Missile Strike on Israel by Iran, ProxiesVietnam Tycoon Lan Sentenced to Death Over $12 Billion FraudFuzz

Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.

In this article you are going to find out whether hedge funds think Mistras Group, Inc. (NYSE:MG) is a good investment right now.